Medical Research
(H32)
990 on File
INFLAMMATORY BREAST CANCER FOUNDATION
Financial strength (30%)
47/100
Reliability (20%)
50/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$8K
Total Revenue
$11K
Total Expenses
$4K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
3.98x
Liability-to-Asset
N/A
Revenue Diversification
100.0%
Compared with Peers
FY 2024
Compared with 782 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 78.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
4.0 mo | 38.9 mo |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
100.0% | 100.0% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
-47.9% | -0.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-24.3% | -6.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-30.6% | 15.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $8K | $11K | $4K | 100.0% | — |
| 2023 | $16K | $14K | $6K | 84.9% | — |
| 2022 | $11K | $17K | $4K | 89.7% | — |
| 2021 | $14K | $24K | $10K | 93.7% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.